Who is doing well in the home dialysis marketplace?

If you guessed NxStage, you’re right! Their revenues are up—and this time from the sales of the System One cycler. That’s good news for home dialyzers.

Read the full article » | Posted 09-05-2014

Related Articles

• Outset Halts Tablo Sales for Home Use Pending FDA Review of New Features Posted 07-13-2022
• Baxter Showcases Kidney Care Products Posted 06-10-2022
• DaVita and Medtronic to Launch New Kidney Tech Company Posted 06-10-2022
• Outset Tablo Could Boost Use of Home Hemodialysis Posted 05-12-2022